Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and reduces life expectancy mainly as it causes lung and respiratory problems.
Researchers at the University of Trento have developed a CRISPR-based adenine base editing therapy that repaired the previously untreatable CFTR 1717-1G>A mutation in patient-derived cell models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results